Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen is a promising clinical-stage biotechnology company that has developed a novel Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its strong pipeline of products, including PGN-EDO51 and PGN-EDODM1, along with a healthy cash position of $132M exiting the 1Q26 period, provide hope for further advancements in their cutting-edge technology. While there may be concerns around commercial execution, competition, and efficacy data, PepGen's recent completion of the 10mg/kg multi-dose cohort in the FREEDOM2 study and the promising data from its earlier 5mg/kg cohort show meaningful progress towards its goals. With this in mind, and considering possible funding needs, the company still remains attractive to investors.

Bears say

PepGen is facing several major challenges that may negatively impact the company's success, including uncertainty around the safety and efficacy of their lead product PGN-EDODM1, as observed in early clinical trials. Additionally, competition in the biotechnology space is increasing, which may impact the demand for PepGen's products in the future. As a result, the financial analyst maintains a negative outlook on PepGen's stock and has lowered their target price to $5 (from $9).

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.